Sorenson, Corinna, Drummond, Michael, Kanavos, Panos and McGuire, Alistair (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? ISPOR connections, 14 (4). pp. 7-9. ISSN 1538-5108
The growing emphasis on evidence-based decision- making in health care, especially regarding health technologies, has generated notable debate and discussion in the U.S. around establishing a more formalized process or system for conducting comparative effectiveness research. In the eyes of many observers, this is quite similar to the HTA programs existing in a number of European countries. The National Institute for three types of guidance, including technology appraisals, clinical guidelines, and interventional procedures. In mid-2005, NICE also assumed the responsibilities of the Health Development Agency (HDA), which provided the Institute with authority to develop guidance on public health interventions or programmes.
|Additional Information:||© 2008 International Society of Pharmacoeconomics and Outcomes Research (ISPOR)|
|Library of Congress subject classification:||J Political Science > JK Political institutions (United States)
R Medicine > RA Public aspects of medicine
|Sets:||Research centres and groups > LSE Health|
Actions (login required)
|Record administration - authorised staff only|